ADVANCED HEALTH LIMITED - Trading Statement

Trading Statement

ADVANCED HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2013/059246/06)
(“the Company” or “Advanced Health”)
ISIN Code: ZAE000189049            
JSE Code: AVL


TRADING STATEMENT


In terms of paragraph 3.4(b)(i) of the Listings Requirements of the JSE Limited, listed companies are required
to publish a trading statement as soon as they become reasonably certain that the financial results for the
next period to be reported on will differ by more than 20% from those of the previous corresponding period.

The directors of Advanced Health hereby advise shareholders that, in respect of the unaudited consolidated
interim results for the period ended 31 December 2019, the loss per share and headline loss per share are
expected to be as follows: -


             Unaudited            Excluding IFRS 16(1)  Unaudited         Excluding IFRS 161   Unaudited
             Six months -         adjustment            Six months -      adjustment           Six months
             31 Dec 2019          Six months -          31 Dec 2019       Six months -              -
             (Including           31 Dec 2019          (Including IFRS    31 Dec 2019          31 Dec 2018
             IFRS 16)(1)                                  16) (1)                               

                         % range between                            between

Loss per     Expected increase of  Expected decrease    Between 7.10      Between 3.56 and      6.21 cents
share        between 14% and       of between 37% and   and 7.84 cents    3.94 cents per        per share
and          26%                   43%                  per share         share
headline
loss per
share
(cents)

Note:
(1)IFRS 16 Leases was adopted using the modified retrospective approach with the date of initial application
being 1 July 2019. Comparative figures were not restated with the cumulative effect of initially applying the
standard recognised at the date of initial application as an adjustment to opening accumulated loss. The
adjustment to accumulated loss amounts to R17.2 million which relates to the reversal of the operating lease
assets and liabilities and the deferred tax thereof recognised as at 30 June 2019.

Further explanations regarding the impact of the adoption of IFRS 16 Leases, will be disclosed in the
Company’s interim results for the six months ended 31 December 2019, which are anticipated to be released
on or about 27 February 2020.

The information in this trading statement has not been reviewed and reported on by the Company’s auditors.
Pretoria

20 February 2020

Designated Advisor
Grindrod Bank Limited

Date: 20-02-2020 01:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.